CU24172B1 - Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización - Google Patents

Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización

Info

Publication number
CU24172B1
CU24172B1 CU20130031A CU20130031A CU24172B1 CU 24172 B1 CU24172 B1 CU 24172B1 CU 20130031 A CU20130031 A CU 20130031A CU 20130031 A CU20130031 A CU 20130031A CU 24172 B1 CU24172 B1 CU 24172B1
Authority
CU
Cuba
Prior art keywords
protection sheet
transdermal therapeutic
therapeutic systems
crystallization inhibiting
inhibiting protection
Prior art date
Application number
CU20130031A
Other languages
English (en)
Other versions
CU20130031A7 (es
Inventor
Estefan Bracht
Ildiko Terebesi
Thomas Langguth
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU24172(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of CU20130031A7 publication Critical patent/CU20130031A7/es
Publication of CU24172B1 publication Critical patent/CU24172B1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CU20130031A 2010-09-06 2011-09-02 Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización CU24172B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010040299A DE102010040299A1 (de) 2010-09-06 2010-09-06 Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
PCT/EP2011/065204 WO2012031985A1 (de) 2010-09-06 2011-09-02 Transdermale therapeutische systeme mit kristallisationsinhibierender schutzfolie (release liner)

Publications (2)

Publication Number Publication Date
CU20130031A7 CU20130031A7 (es) 2013-05-31
CU24172B1 true CU24172B1 (es) 2016-04-25

Family

ID=44653285

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20130031A CU24172B1 (es) 2010-09-06 2011-09-02 Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización

Country Status (32)

Country Link
US (2) US8557279B2 (es)
EP (1) EP2613771A1 (es)
JP (2) JP6104800B2 (es)
KR (1) KR20130114127A (es)
CN (1) CN103079549B (es)
AP (1) AP3586A (es)
AR (1) AR082907A1 (es)
AU (1) AU2011298892B2 (es)
BR (1) BR112013005305A2 (es)
CA (1) CA2810103C (es)
CL (1) CL2013000636A1 (es)
CO (1) CO6690753A2 (es)
CR (1) CR20130098A (es)
CU (1) CU24172B1 (es)
DE (1) DE102010040299A1 (es)
DO (1) DOP2013000053A (es)
EA (1) EA032575B1 (es)
EC (1) ECSP13012477A (es)
GT (1) GT201300062A (es)
IL (2) IL224980A (es)
MA (1) MA34581B1 (es)
MX (1) MX2013002602A (es)
MY (1) MY162768A (es)
NZ (1) NZ607630A (es)
PE (2) PE20180198A1 (es)
SG (2) SG10201506927TA (es)
TN (1) TN2013000087A1 (es)
TW (1) TWI576245B (es)
UA (1) UA110217C2 (es)
UY (1) UY33590A (es)
WO (1) WO2012031985A1 (es)
ZA (1) ZA201301389B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (es) 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
PT99338A (pt) 1990-10-29 1992-10-30 Alza Corp Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
DE4210711A1 (de) 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
PT1242012E (pt) 1999-11-24 2010-03-31 Agile Therapeutics Inc Sistema e processo melhorado de libertação transdérmica de contraceptivo
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
AU2002235155A1 (en) 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
EP1216699A1 (de) 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
US20030165547A1 (en) * 2001-05-18 2003-09-04 Elisabeth Picard-Lesboueyries Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
EP1594483B1 (de) * 2003-02-21 2006-07-19 Schering AG Uv-stabiles transdermales pflaster
EA011160B1 (ru) 2003-12-12 2009-02-27 Шеринг Акциенгезельшафт Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
WO2006044206A2 (en) * 2004-10-08 2006-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
DE102004062182B4 (de) 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
JP2012504609A (ja) * 2008-10-06 2012-02-23 マイラン・テクノロジーズ,インコーポレイテッド アモルファスロチゴチン経皮システム

Also Published As

Publication number Publication date
TWI576245B (zh) 2017-04-01
ECSP13012477A (es) 2013-04-30
AR082907A1 (es) 2013-01-16
IL224980A (en) 2017-07-31
EA032575B1 (ru) 2019-06-28
CA2810103A1 (en) 2012-03-15
BR112013005305A2 (pt) 2016-08-16
ZA201301389B (en) 2021-05-26
MY162768A (en) 2017-07-14
IL251124B (en) 2020-07-30
CN103079549B (zh) 2016-11-02
AU2011298892B2 (en) 2015-03-12
US20120082714A1 (en) 2012-04-05
PE20180198A1 (es) 2018-01-26
CO6690753A2 (es) 2013-06-17
DE102010040299A1 (de) 2012-03-08
UY33590A (es) 2011-10-31
TN2013000087A1 (en) 2014-06-25
AU2011298892A1 (en) 2013-03-28
JP6104800B2 (ja) 2017-03-29
EP2613771A1 (de) 2013-07-17
DOP2013000053A (es) 2013-07-15
UA110217C2 (en) 2015-12-10
TW201217165A (en) 2012-05-01
SG10201506927TA (en) 2015-10-29
EA201390246A1 (ru) 2013-09-30
CA2810103C (en) 2019-06-18
NZ607630A (en) 2015-02-27
US20140018751A1 (en) 2014-01-16
AP2013006787A0 (en) 2013-04-30
KR20130114127A (ko) 2013-10-16
JP2016216500A (ja) 2016-12-22
US8557279B2 (en) 2013-10-15
AP3586A (en) 2016-02-10
PE20131138A1 (es) 2013-10-26
WO2012031985A1 (de) 2012-03-15
CR20130098A (es) 2013-05-15
CN103079549A (zh) 2013-05-01
JP2013536828A (ja) 2013-09-26
US9060955B2 (en) 2015-06-23
GT201300062A (es) 2015-01-16
SG187941A1 (en) 2013-04-30
MA34581B1 (fr) 2013-10-02
CU20130031A7 (es) 2013-05-31
IL251124A0 (en) 2017-04-30
MX2013002602A (es) 2013-04-08
CL2013000636A1 (es) 2013-09-13

Similar Documents

Publication Publication Date Title
CO7000779A2 (es) Sistema de administración transdermica
FR2979441B3 (fr) Etui de protection
BR112013016823A2 (pt) sistemas de expressão
BR112013021985A2 (pt) proteção de agulha
FR2956565B1 (fr) Casque de protection
BR112013012231A2 (pt) sistema de proteção contra perfuração
EP2545625A4 (en) LINE PROTECTION SYSTEMS
DK3413000T3 (da) Afskærmningssystem
GB201012398D0 (en) Protection system
BR112014015218A8 (pt) sistemas de afastadores cirúrgicos
DE102010060938A8 (de) Kontrollsystem
DK2864523T3 (da) Katodisk beskyttelsessystem
EP2836624A4 (en) CATHODIC PROTECTION SYSTEM
SI2565290T1 (sl) Balistični zaščitni sistem
DE112010005767A5 (de) Insassenschutzsystem
CU24172B1 (es) Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización
PL2761245T3 (pl) Aktywny system obronny
FR2961660B1 (fr) Barriere de protection souple
FR2972247B3 (fr) Structure de protection flexible amelioree
IT1399112B1 (it) Dispositivo antincendio
ES1072231Y (es) Panel de señalizacion
ES1072666Y (es) Dispositivo de proteccion
ZA201200932B (en) Protection system
GB2476942B (en) Flood prevention system
FI8952U1 (fi) Suoja

Legal Events

Date Code Title Description
FG Grant of patent